Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | USP2 | O75604 | 1/20 | 0.44 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.42 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.42 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.42 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.42 |
| ▸ | ACKR3 | P25106 | 3/20 | 0.41 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.41 |
| ▸ | HTR1A | P08908 | 1/20 | 0.41 |
| ▸ | EPHX2 | P34913 | 4/20 | 0.41 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.39 |
| ▸ | GPR4 | P46093 | 1/20 | 0.39 |
| ▸ | NAMPT | P43490 | 1/20 | 0.39 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.39 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25905171 | 1.00 | SMN1; SMN2 (0.44) | SMN1; SMN2USP2CHRM2CHRM4CHRM1 | |
| SCHEMBL5560225 | 0.98 | SMN1; SMN2 (0.45) | SMN1; SMN2USP2CHRM2CHRM4CHRM1 | |
| SCHEMBL1730281 | 0.96 | SMN1; SMN2 (0.43) | SMN1; SMN2USP2CHRM2CHRM4CHRM1 | |
| SCHEMBL6661328 | 0.88 | USP2 (0.44) | SMN1; SMN2USP2CHRM2CHRM4CHRM1 | |
| SCHEMBL22262696 | 0.88 | USP2 (0.44) | SMN1; SMN2USP2CHRM2CHRM4CHRM1 | |
| SCHEMBL25678515 | 0.88 | TLR8 (0.46) | SMN1; SMN2USP2CHRM2CHRM4CHRM1 | |
| SCHEMBL15352136 | 0.88 | USP2 (0.44) | SMN1; SMN2USP2CHRM2CHRM4CHRM1 | |
| SCHEMBL23251655 | 0.88 | USP2 (0.46) | SMN1; SMN2USP2CHRM2CHRM4CHRM1 | |
| SCHEMBL20572924 | 0.87 | USP2 (0.43) | SMN1; SMN2USP2CHRM2CHRM4CHRM1 | |
| SCHEMBL25326510 | 0.87 | USP2 (0.43) | SMN1; SMN2USP2CHRM2CHRM4CHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4626553-A2 | TLR7 AGONISTS AND ANTIBODY-DRUG-CONJUGATES THEREOF | Regeneron Pharmaceuticals, Inc. (US) | 2025-10-08 | — | — | EP | disclosed |
| WO-2024118785-A2 | TLR7 AGONISTS AND ANTIBODY-DRUG-CONJUGATES THEREOF | REGENERON PHARMACEUTICALS, INC. (US) | 2024-06-06 | — | — | WO | disclosed |
| WO-2014016202-A1 | METHODS FOR CATALYTIC ALKYLATION OF NUCLEIC ACIDS | UNIVERSITÄT BASEL (CH) | 2014-01-30 | — | — | WO | disclosed |
| EP-2689847-A1 | Methods for catalytic alkylation of nucleic acids | Universität Basel (CH) | 2014-01-29 | — | — | EP | disclosed |
| EP-2689847-A1 | Methods for catalytic alkylation of nucleic acids | Universität Basel (CH) | 2014-01-29 | — | — | EP | disclosed |